世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028096

製薬業界のパートナーシップ・ライセンス契約・投資・M&A取引動向 −月次取引分析(2020年8月)

GlobalData

Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - August 2020

発刊日 2020/09/30

言語英語

体裁PDF/92ページ

「PDF」版92ページ

0000028096

製薬業界のパートナーシップ・ライセンス契約・投資・M&A取引動向 −月次取引分析(2020年8月)
Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - August 2020

1,000 USD

※商品のお問い合わせはこちらより可能です。

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、製薬業界におけるパートナーシップ、ライセンス契約、M&A、および資金調達に関するデータと傾向分析の重要な情報源です。本レポートは、2020年8月に製薬業界に登録されたパートナーシップおよびライセンス取引、M&A、株式/債券の新規発行、未公開株取引(プライベートエクイティ)、およびベンチャー資金調達に関する詳細情報を提供します。また、過去6か月間の取引数とその価値に関する詳細な比較データを、取引の種類、さまざまな治療分野、地域ごとに分類して示しています。さらに、製薬業界のトップ財務顧問会社に関する情報を提供します。

本レポートに示されているデータは、GlobalData社独自の製薬に関する社内データベース(Pharmaceuticals eTrack)と一次および二次調査から得られたものです。

■ 調査範囲

  • 世界的な製薬業界の市場動向の分析
  • 心血管系、中枢神経系、皮膚科、耳鼻咽頭疾患、胃腸、泌尿生殖器および性ホルモン、造血系疾患、ホルモン性疾患、免疫学、感染症、男性の健康、代謝性疾患、口腔および歯科疾患、筋骨格、腫瘍学、眼科、呼吸器、毒物学、および女性の健康の分野におけるに取引動向のレビュー
  • 製薬業界におけるパートナーシップ、ライセンス契約、M&A、株式/債券の新規発行、未公開株取引(プライベートエクイティ)、およびベンチャー資金調達取引の分析
  • ベンチャーキャピタルの資金調達、パートナーシップ、ライセンス契約、株式/債券の新規発行、およびM&Aの観点から非常に活発な治療分野の分析
  • 主に製薬業界のパートナーシップおよびライセンス契約における、前払いおよびマイルストーン支払いを含む、さまざまな支払いモードに基づく取引の分析
  • 製品開発の臨床段階に基づくパートナーシップおよびライセンス契約の分析
  • 6か月間の世界的な医薬品取引の概要
  • 製薬業界で起こったトップ取引に関する情報
  • 対象地域:北アメリカ、ヨーロッパ、アジア太平洋地域、中南米、中東およびアフリカ
  • M&Aおよび株式/債券の新規発行における財務顧問(Morgan Stanley社、Credit Suisse社、Goldman Sachs社などの主要企業を含む)のリーグテーブル

レポート詳細

目次

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2020
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2020
2.2.1 Siemens Healthineers to Acquire Varian for USD16.4 Billion
2.2.2 Johnson & Johnson Raises USD7.5 Billion in Public Offering of Notes
2.2.3 Johnson & Johnson to Acquire Momenta Pharma
2.2.4 Gilead Sciences and Tango Therapeutics Enter into Collaboration
2.2.5 Royalty Pharma Raises USD6 Billion in Private Placement of Notes
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2020
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2020

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2020
3.1.1 Top M&A Deals in August 2020
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2020- August 2020
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2020
3.2.1 Top Equity Offering Deals in August 2020
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2020- August 2020
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2020
3.3.1 Top PE/VC Deals in August 2020
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2020
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2020
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2020-August 2020
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2020-August 2020
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2020
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2020- August 2020
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2020
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2020- August 2020
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2020- August 2020
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2020- August 2020

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2020
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2020
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2020
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2020- August 2020
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2020- August 2020
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2020- August 2020
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2020- August 2020
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2020
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2020
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2020

5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2020
5.1.1 Oncology - Deals of the Month
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2020
5.2.1 Central Nervous System - Deals of the Month
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2020
5.3.1 Infectious Diseases - Deals of the Month
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2020
5.4.1 Cardiovascular - Deals of the Month
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2020
5.5.1 Immunology - Deal of the Month
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, August 2020
5.6.1 Metabolic- Deals of the Month
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Disorders, Deals, August 2020
5.7.1 Gastrointestinal - Deals of the Month

6 Deal Summary by Geography

7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors

8 Further Information

List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2020
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2020
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2020
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2020
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2020
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2020- August 2020
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2020
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2020- August 2020
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), March 2020- August 2020
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), August 2020
Table 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, March 2020- August 2020
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2020
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2020
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2020
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 37: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 38: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020

List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2020
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2020
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2020
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2020
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2020- August 2020
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), March 2020- August 2020
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 32: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 33: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2020- August 2020

この商品のレポートナンバー

0000028096

TOP